Pharma CEO, Daughter To Pay $2M In SEC Stock Fraud Case
The Texas-based CEO of a purported pharmaceutical company and his daughter will pay nearly $2 million to end the U.S. Securities and Exchange Commission's claims accusing them and several others of...To view the full article, register now.
Already a subscriber? Click here to view full article